Control Bionics Ltd CBL:ASX

*Data is delayed | AUD
Last | 3:52 PM AET
0.635quote price arrow up+0.005 (+0.79%)
Volume
19,742
52 week range
0.58 - 1.24

...

Loading . . .
  • Open0.635
  • Day High0.65
  • Day Low0.635
  • Prev Close0.63
  • 52 Week High1.24
  • 52 Week High Date12/08/20
  • 52 Week Low0.58
  • 52 Week Low Date03/19/21

Key Stats

  • Market Cap45.32M
  • Shares Out83.33M
  • 10 Day Average Volume71,913.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-32.45

KEY STATS

  • Open0.635
  • Day High0.65
  • Day Low0.635
  • Prev Close0.63
  • 52 Week High1.24
  • 52 Week High Date12/08/20
  • 52 Week Low0.58
  • 52 Week Low Date03/19/21
  • Market Cap45.32M
  • Shares Out83.33M
  • 10 Day Average Volume71,913.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-32.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-25.40
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Control Bionics Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Control Bionics Ltd is an Australia-based company that designs, manufactures and sells wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology products. The Company’s products are NeuroNode 3 and NeuroNode Trilogy and NeuroNode GridPad Trilogy. The Company’s products allows users to operate and communicate via a computer using intentional thought and the body’s own neuroelectric signals transmitted to skeletal muscle sites....
Address
23-25 O'Connell Street, Level 5
Sydney, NSW
2000
Australia